Plexxikon completes $27mm Series B round; gets another $15mm
Small-molecule drug discovery start-up Plexxikon raised $27mm in a Series B private placement to lead investor Walden International. Also participating in the round were other new investors GIMV and AM Pappas, along with return investors Alta Partners, CW Group, Advanced Technology Ventures, and Kumho Group.
- Large Molecule
Drug Discovery Technologies
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com